Source of support: Self financing Roughly 60 % of hearts offered for transplantation are rejected because of organ dysfunction. Moreover, hearts from circulatory-dead patients have long been thought to be non-amenable for transplantation, unlike other organs. However, tentative surgical attempts inspired by the knowledge obtained from preclinical research to recover those hearts have been performed, finally culminating in clinically successful transplants. In this re-view we sought to address the major concerns in non-heart-beating donor heart transplantation and highlight recently introduced developments to overcome them
Purpose of Study: Donor heart selection for heart transplantation is not standardized. Donor hearts ...
Donation After Circulatory Death (DCD) is an alternative to Donation after Brain Death (DBD), and is...
Despite the widespread use of mechanical circulatory support systems, modern optimal drug therapy an...
Heart transplantation provides a substantial survival benefit for selected patients with advanced he...
Full list of author information is available at the end of the articleIntroduction Heart transplanta...
[Abstract] Heart transplantation is advocated in selected patients with advanced heart failure in th...
BACKGROUND: Decision-making when offered a donor heart for transplantation is complex, and supportiv...
peer reviewedHeart transplantation remains the only definite treatment option for end-stage heart di...
BACKGROUND: Decision-making when offered a donor heart for transplantation is complex, and supportiv...
Heart transplantation is advocated in selected patients with advanced heart failure in the absence o...
Purpose: The purpose of this article is to review how donor heart utilization has evolved over time ...
Cardiac transplantation is an accepted therapy for patients with end-stage heart failure (ESHF). Pre...
Cardiac Transplantation remains the definitive treatment of End-Stage Heart Failure beyond medical t...
Background: Heart transplantation remains to date the only definite treatment option for end-stage h...
Despite advances in mechanical circulatory devices and pharmacologic therapies, heart transplantatio...
Purpose of Study: Donor heart selection for heart transplantation is not standardized. Donor hearts ...
Donation After Circulatory Death (DCD) is an alternative to Donation after Brain Death (DBD), and is...
Despite the widespread use of mechanical circulatory support systems, modern optimal drug therapy an...
Heart transplantation provides a substantial survival benefit for selected patients with advanced he...
Full list of author information is available at the end of the articleIntroduction Heart transplanta...
[Abstract] Heart transplantation is advocated in selected patients with advanced heart failure in th...
BACKGROUND: Decision-making when offered a donor heart for transplantation is complex, and supportiv...
peer reviewedHeart transplantation remains the only definite treatment option for end-stage heart di...
BACKGROUND: Decision-making when offered a donor heart for transplantation is complex, and supportiv...
Heart transplantation is advocated in selected patients with advanced heart failure in the absence o...
Purpose: The purpose of this article is to review how donor heart utilization has evolved over time ...
Cardiac transplantation is an accepted therapy for patients with end-stage heart failure (ESHF). Pre...
Cardiac Transplantation remains the definitive treatment of End-Stage Heart Failure beyond medical t...
Background: Heart transplantation remains to date the only definite treatment option for end-stage h...
Despite advances in mechanical circulatory devices and pharmacologic therapies, heart transplantatio...
Purpose of Study: Donor heart selection for heart transplantation is not standardized. Donor hearts ...
Donation After Circulatory Death (DCD) is an alternative to Donation after Brain Death (DBD), and is...
Despite the widespread use of mechanical circulatory support systems, modern optimal drug therapy an...